Literature DB >> 6169790

Antigenic and biological relationships between human coronavirus OC43 and neonatal calf diarrhoea coronavirus.

G Gerna, P M Cereda, M G Revello, E Cattaneo, M Battaglia, M T Gerna.   

Abstract

Monospecific antisera were prepared in mice to human coronavirus OC43 and neonatal calf diarrhoea coronavirus (NCDCV) which had been previously adapted to growth in suckling mouse brain. Brain suspension from infected suckling mice was used as immunogen. The antigenic relationship between OC43 and NCDCV was studied by the indirect immunoperoxidase antibody technique, by the haemagglutination-inhibition (HI) test and a new infectious centre-reduction neutralization test. In mouse immune sera, a two-way cross-reaction between OC43 and NCDCV was detected. However, the antigenic relationship appeared to be closer for internal (as shown by immunoperoxidase staining) as compared to surface antigens (as shown by HI and neutralization). In primary infections of natural hosts there was a high degree of cross-reactivity between the two coronavirus strains for both surface and internal antigens, and homologous and heterologous titres were consistently within an eightfold dilution difference by all tests. Most human adults and calves had antibody to both OC43 and NCDCV and geometric mean titres of homologous antibody were higher than titres of heterologous antibody. Although OC43 and NCDCV share antigenic determinants, they possessed several different biological properties, including plaque morphology by the infectious centre assay, agglutination of 1-day-old chick erythrocytes and resistance of haemagglutinin to physical and chemical treatments.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6169790     DOI: 10.1099/0022-1317-54-1-91

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Antigenic and genomic relationships among turkey and bovine enteric coronaviruses.

Authors:  S Dea; A J Verbeek; P Tijssen
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

2.  Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay.

Authors:  L J Anderson; J C Hierholzer; P G Bingham; Y O Stone
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

3.  Antigenic relationships among homologous structural polypeptides of porcine, feline, and canine coronaviruses.

Authors:  M C Horzinek; H Lutz; N C Pedersen
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

Review 4.  The molecular biology of coronaviruses.

Authors:  L S Sturman; K V Holmes
Journal:  Adv Virus Res       Date:  1983       Impact factor: 9.937

Review 5.  Serological assays for emerging coronaviruses: challenges and pitfalls.

Authors:  Benjamin Meyer; Christian Drosten; Marcel A Müller
Journal:  Virus Res       Date:  2014-03-23       Impact factor: 3.303

6.  Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study.

Authors:  Chantal B E M Reusken; Bart L Haagmans; Marcel A Müller; Carlos Gutierrez; Gert-Jan Godeke; Benjamin Meyer; Doreen Muth; V Stalin Raj; Laura Smits-De Vries; Victor M Corman; Jan-Felix Drexler; Saskia L Smits; Yasmin E El Tahir; Rita De Sousa; Janko van Beek; Norbert Nowotny; Kees van Maanen; Ezequiel Hidalgo-Hermoso; Berend-Jan Bosch; Peter Rottier; Albert Osterhaus; Christian Gortázar-Schmidt; Christian Drosten; Marion P G Koopmans
Journal:  Lancet Infect Dis       Date:  2013-08-09       Impact factor: 25.071

7.  Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.

Authors:  Giuseppe Gerna; Giulia Campanini; Francesca Rovida; Elena Percivalle; Antonella Sarasini; Antonietta Marchi; Fausto Baldanti
Journal:  J Med Virol       Date:  2006-07       Impact factor: 2.327

8.  Sequence analysis of nucleocapsid gene and leader RNA of human coronavirus OC43.

Authors:  T Kamahora; L H Soe; M M Lai
Journal:  Virus Res       Date:  1989-01       Impact factor: 3.303

9.  Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013.

Authors:  Benjamin Meyer; Marcel A Müller; Victor M Corman; Chantal B E M Reusken; Daniel Ritz; Gert-Jan Godeke; Erik Lattwein; Stephan Kallies; Artem Siemens; Janko van Beek; Jan F Drexler; Doreen Muth; Berend-Jan Bosch; Ulrich Wernery; Marion P G Koopmans; Renate Wernery; Christian Drosten
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

Review 10.  Features of enteric disease from human coronaviruses: Implications for COVID-19.

Authors:  Nevio Cimolai
Journal:  J Med Virol       Date:  2020-06-05       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.